EMISRLOW SIGNALFINANCIAL10-Q

EMISR updated its quarterly reporting from Q2 to Q3 2025, showing improved liquidity position as the blank check company moved from having no cash to $1.4 million in cash and positive working capital.

This appears to be a routine quarterly progression for a newly formed SPAC, with the company successfully raising capital and establishing its trust account. The improved cash position and positive working capital indicate the company has completed its initial fundraising activities and is now positioned to pursue acquisition opportunities.

Comparing 2025-11-13 vs 2025-11-04View on EDGAR →
FINANCIAL ANALYSIS

The company's financial position improved meaningfully from Q2 to Q3 2025, transitioning from a working capital deficit of $84,280 with no cash to a working capital surplus of $1.27 million with $1.45 million in cash. Operating losses increased modestly to $165K, while total liabilities grew to $125K, reflecting typical early-stage operational expenses for a blank check company establishing its operations and building its trust account of over $115 million.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
-74.2%
-$95K-$165K

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Total Liabilities
Balance Sheet
+29.2%
$97K$125K

Liabilities increased 29.2% — monitor debt-to-equity ratio and interest coverage.

Current Liabilities
Balance Sheet
+29.2%
$97K$125K

Current liabilities rose 29.2% — increased short-term obligations, watch current ratio.

Stockholders Equity
Balance Sheet
-15.4%
$1.1M$909K

Equity decreased 15.4% — buybacks or losses reducing book value, monitor solvency ratios.

LANGUAGE CHANGES
NEW — 2025-11-13
PRIOR — 2025-11-04
ADDED
(the Company ) is a blank check company incorporated as a Cayman Islands exempted company on March 21, 2025.
As of September 30, 2025, the Company had not commenced any operations.
At September 30, 2025, the Company had $ 1,446,437 cash and had a working capital surplus of $ 1,265,828 .
In connection with the Company s assessment of going concern considerations in accordance with Accounting Standards Codification ( ASC ) 205-40, Presentation of Financial Statements - Going Concern , the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business.
The Company had $ 1,446,437 in cash and no cash equivalents as of September 30, 2025.
+7 more — sign up free →
REMOVED
1 0002075816 --12-31 false Q2 Rights, each right entitling the holder to receive one-tenth (1/10) of one http://fasb.org/srt/2025#ChiefFinancialOfficerMember (1) Excludes an aggregate of 500,000 Class B ordinary shares subject to forfeiture if the over-allotment is not exercised in full or in part by the underwriters.
Includes an aggregate of 500,000 Class B ordinary shares subject to forfeiture if the over-allotment is not exercised in full or in part by the underwriters.
Interim Financial Statements Condensed Balance Sheet as of June 30, 2025 (Unaudited) 1 Condensed Statements of Operations for the three months ended and for the period from March 21, 2025 (Inception) through June 30, 2025 (Unaudited) 2 Condensed Statements of Changes in Shareholder s Deficit for the three months ended and for the period from March 21, 2025 (Inception) through June 30, 2025 (Unaudited) 3 Condensed Statement of Cash Flows for the period from March 21, 2025 (Inception) through June 30, 2025 (Unaudited) 4 Notes to Condensed Financial Statements (Unaudited) 5 Item 2.
(the Company ) is a blank check company incorporated as a Cayman Islands exempted company on March 21, 2025 .
As of June 30, 2025, the Company had not commenced any operations.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →